Mild synthesis of [N-methyl-11C]-isovaleroyl-(L)-carnitine. The usefulness of a tritium approach

Applied Radiation and Isotopes

Volumn 50, Issue 2, 1999, Pages 303-309

  Angelini, G ^a   Carnevaletti, F ^a   Margonelli, A ^a   Corsi, G ^a   Ragni, P ^a   Fazio, F ^b   Todde, S ^b   Tinti, O ^c  

^a CNR   (Italy)

^b Ist di Neuroscienze e Bioimmagini   (Italy)

^c Sigma Tau SpA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DERIVATIVES; IODINE COMPOUNDS; RADIOACTIVE TRACERS; SYNTHESIS (CHEMICAL); TRITIUM;

CARNITINE; RADIOSYNTHESIS;

VITAMINS;

CARNITINE; METHYL IODIDE; TRITIUM;

ARTICLE; DRUG SYNTHESIS; FATTY ACID METABOLISM; HALF LIFE TIME; MITOCHONDRIAL MEMBRANE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROPIONIC ACIDEMIA; SKELETAL MUSCLE; TISSUE DISTRIBUTION;

EID: 0033081795     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8043(97)10135-X     Document Type: Article

References (17)

1. 11C molecules for medical research on a microscale: a theoretical and pratical approach J. Label. Comp. Radiopharm. 18:1981;1649.
2. Borum P. R. Nutr. Rev. 39:1981;385.
3. Anon., 1991. Cardiovascular Drugs and Therapy, vol. 5 (Suppl. 1).
4. Chapoy P. R., Angelini C., Brown W. J., Stiff J. E., Shug A. L., Cederbaum S. D. Systemic carnitine deficiency - A treatable inherited lipid-storage disease presenting as Reye's syndrome. New Eng. J. Med. 303:1980;1389.
5. 11C ]methyl iodide Appl. Radiat. Isot. 38:1987;601. and references therein.
6. Crouzel, C., Clark, C. J., Brihayl, C., Langstrom, B., Lemaire, C., Meyer, J. G., Nebeling, B., Stone-Elander, S., 1993. Radiochemistry automation for PET. In: Stocklin, G., Pike, V. W. (Eds.), Radiopharmaceuticals for Positron Emission Tomography. Methodological Aspects. Kluwer Ac. Publ., Dordrecht, pp. 45-79.
7. Dannals, R. F., Ravert, H. T., Wilson, A. A., Wagner, H. N., Jr., 1991. Special problems associated with the synthesis of high specific activity Carbon-11 labeled radiotracers. In: Emran, A. M. (Ed.), New Trends in Radiopharmaceutical Synthesis, Quality Assurance and Regulatory Control. Plenum Press, N.Y., pp. 21-30.
8. 11C ]-propionyl-L-carnitine for human distribution studies J. Label. Comp. Radiopharm. 35:1994;329.
9. Engel, A. G., 1980. In: Frenkel, R. A., McGarry, J. D. (Eds.), Carnitine Biosynthesis, Metabolism and Function. Academic Press, N.Y.
10. Harada N., Hayashi N. Measurement of the carbon source which is responsible for dilution in Carbon-11 labelling reactions. Appl. Radiat. Isot. 44:1993;629.
11. Holschbach M., Hamkens W., Roden W., Feinendegen L. E. Synthesis of carbon-11 labeled (R)-carnitine. J. Label. Comp. Radiopharm. 29:1990;599.
12. 11C ]methyl iodide Appl. Radiat. Isot. 44:1993;779.
13. 11C ]acetyl-L-carnitine into the brain: a PET study Biochem. Biophys. Res. Commun. 231:1997;488.
14. 11C -methiodide quinuclidinyl benzilate. A muscarinic antagonist for in-vivo studies of myocardial muscarinic receptors J. Radioanal. Chem. 76:1983;305.
15. Millington, D. S., Maltby, D. A., Gale, D., Roe, C. R., 1988. Synthesis and human applications of stable isotope-labelled L-carnitine. In: Ballie, T. A., Jones, J. R. (Eds.), Synthesis and Application of Isotopically Labelled Compounds. Elsevier Sc. Pub., Amsterdam, pp. 189-194.
16. Ruth T. J., Adam M. J. Synthesis of C-11 and F-18 labeled compounds for biomedical applications: current status and challenges for the future. J. Radioanal. Nuclear Chem. Articles. 203:1996;457.
17. Thomsen J. H., Shug A. L., Yap U. V., Patel A. K., Karras T. J., DeFelice S. L. Improved pacing tolerance of the ischemic human myocardium after administration of carnitine. Am. J. Cardiol. 43:1979;300.